The Cancer Prevention and Research Institute of Texas (CPRIT) recently awarded an additional grant to researchers in the NCI-designated Dan L. Duncan Cancer Center at Baylor College of Medicine to continue their cancer-related research projects. The additional funds bring the total grant to $9.9 million.
Initially, BCM received a $5.9 million CPRIT for three early translational research projects — the highest amount of money awarded to an institution in that scientific area in the state. Now, an additional $4 million in funding will be used to help recruit promising first-time and tenure-track faculty members.
Baylor College of Medicine aims to achieve excellency in patient care and is dedicated to providing high level education for students, all while fostering innovative research for cancer prevention and treatment. Outreach and education to undeserved communities are high priorities for the institution as well.
This new grant from the state cancer program strengthens the institution’s research role in cancer, bringing the total dollars granted by CPRIT to $130 million.
- Dr. Debananda Pati, professor of pediatrics — oncology at Baylor and a member of the Texas Children’s Cancer Center, for a $2 million grant project entitled Novel Separase Inhibitors to Treat Refractory Breast Cancer
- Dr. David Tweardy, professor of medicine — infectious diseases, for a $1,999,569 grant project entitled Oral Stat3 Inhibitor as Targeted Treatment for Triple-negative Breast Cancer
- Dr. Leonid Metelitsa, associate professor of pediatrics — oncology at Baylor and a member of the Texas Children’s Cancer Center, for a $1,928,220 grant project entitled NKT Cell Platform for Cancer Immunotherapy
To recruit first-time, tenure track faculty members, the individual awards included a $2 million grant to help recruit Dr. Xi Chen, currently a post-doctoral associate at Weill Cornell Medical College, and a $2 million grant to help recruit Dr. Melanie Samuel, currently a post-doctoral fellow at Harvard University.
CPRIT is committed to finding a cure for cancer and dedicated to put Texas at the center of cancer research. CPRIT awarded 20 grants for a total of $65 million for developing products, translational and recruitment programs and prevention.